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1. Introduction
   Degenerative cervical disc narrowing is a common 
cause of neck pain, radiculopathy, and myelopathy due 
to degenerative disc disease (DDD). Over the past fifty 
years, anterior approach for cervical decompression with 
or without fusion has provided good clinical results[1]. 
However, several complications about cervical arthrodesis 
included graft collapse, graft expulsion, pseudoarthrosis, 
donor-site morbidity, neck stiffness, cervical lordotic 
loss[2,3], and accelerated degeneration at adjacent levels 
caused from arthrodesis were also reported[4-6].
   Total disc replacement (TDR) is an increasingly accepted 
and diffusing technique used to treat cervical DDD. 
Symptomatic patients with soft disc hernia or moderate 
DDD can be considered for TDR. In consideration about 
the postoperative deterioration due to arthrodetic surgery, 
cervical artificial disc replacement was developed to 
preserve mobility of the implantation level, avoid deformity 
of spinal column, reduce stresses on adjacent discs, and 
restore intervertebral height to achieve decompression 
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without filling any bone grafts. At present, cervical disc 
replacement has demonstrated good clinical results in 
managing single- or multi-level spondylotic radiculopathy, 
myelopathy alone, or combined both of the symptoms[7-
10], and could also maintain the range of motion in flexion/
extension activity[11,12]. Previous in vitro investigation 
has also found that cervical disc replacement maintained 
intradiscal pressures at adjacent level and approximate 
kinematics of reconstructed level as performances of intact 
spine[13].
   Surgical treatment for severe cervical disc narrowing 
involves anatomic correction of the degenerative pathologic 
entities that compress a nerve root or the spinal cord. 
Severe cervical disc narrowing would significantly result 
in decrease of mobility of motion segment[14-16], which 
would also be the main reason to increase the adjacent 
level degeneration and symptoms. In cases of severe disc 
narrowing, the complication rates are probably higher 
mainly due to the fact that frequently multiple levels are 
operated.
   Previous literature has reported the use of Bryan disc in 
cervical disc narrowing. However, application of cervical 
disc replacement specifically for treating severe cervical 
disc narrowing has never been performed. The purpose 
of this study was to firstly demonstrate the application of 
Bryan disc on treatment of severe cervical disc narrowing. 
In addition, clinical and radiologic outcomes of patients in 
single- and multi-level replacement during the follow-up 
period were evaluated. Neurological symptoms and signs, 
stability, and mobility restoration were considered in these 
postoperative follow-ups.
 
2. Materials and methods
2.1. Patient population
   This study recruited 41 arthroplasties from 32 patients (18 
males and 14 females) using the Bryan cervical disc system 
(Medtronic Sofamor Danek, Memphis, TN, USA) from April 
2006 to February 2010 in Chi-Mei Medical Center, Tainan, 
Taiwan. Among these 32 patients, a single level procedure 
was performed in 24 patients, a two-level procedure in 
seven patients and a three-level procedure in one patient. 
All the surgeries were performed by one senior surgeon of 
the authors. A comprehensive grading system for cervical 
disc degeneration was executed based on the reported 
literature[16]. Inclusion criteria included grade V disc 
degeneration, over 40% collapse of normal disc height, and 
marked osteophytes (more than 2 mm) as shown in Figures 
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Figure 1. A 51-year-old woman had the osteophyte (a) and T2-weighted midsagittal image reveals a grade V cervical intervertebral disc 
degeneration at C5-6 (b). One-month postoperative lateral radiograph after replacement at C5-6 shows the range of motion was 3.0曘calculated 
from flexion radiograph (c) and extension radiograph (d). After two years, the range of motion is 11.7曘calculated from flexion (e) and extension (f). 
-:  lordosis; +: kyphosis.
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1a and 2a. Patients with active systemic infection, allergy 
to implantation materials, osteoporosis, marked cervical 
instability, deformity, significant facet joint arthropathy, 
trauma, and tumor were excluded. Preoperative and 
postoperative Japanese Orthopedics Association (JOA) 
score, visual analog scale (VAS) and Odom’s scale[17] were 
recorded for outcome analysis. Odom’s scale was used as it 
is the most commonly used scale and is relatively simple. 
Quantitative information of patients was summarized in 
Table 1.
Table 1 
Information of implantation levels of patients inquired.
Item Number Averaged (mean依SD) Range
Age (year old) -  54.9依12.6 33-66
Preoperative VAS score -   6.3依2.2 2-9
Preoperative JOA score - 14.4依1.2 12-16
Implantation level
C3-C4  7 - -
C4-C5 10 - -
C5-C6 18 - -
C6-C7   6 - -
2.2. Radiological analysis
   All patients were preoperatively evaluated with static or 
dynamic cervical spine radiographs and magnetic resonance 
imaging. The magnetic resonance imaging was used to 
determine the radiculopathic or myelopathic origin. On T2-
weighted midsagittal images, hypointense nucleus signal 
intensity, inhomogeneous gray to black nucleus structure 
and nucleus distinction loss and annulus, and disc height 
collapse were defined as grade V cervical intervertebral disc 
degeneration[16]. In this preoperative examination, A total 
of 12 patients with abnormal T2 cord signal met the clinical 
myelopathy criteria. Dynamic cervical spine radiographs 
were postoperatively obtained in one month, six months, 
12 months, 18 months and 36 months. To analyze mobility 
at the proposed levels of replacement, angular range of 
motion was determined on the full flexion and extension 
radiographs. The angular range of motion was determined 
by drawing a line along the superior endplate of the cranial 
vertebrae and the inferior endplate of the caudal vertebrae. 
The difference between the angles on the 2 radiographs at 
each level was the range of motion. The mobility range of 
functional cervical spinal unit was defined as the difference 
in the Cobb’s angle between the full flexion and extension 
according to lateral radiographs. Pre- and postoperative 
variation of mobility ranges in follow-ups for all patients 
inquired were recorded for evaluation. Measurements 
of postoperative range of motion were performed by two 
experienced orthopaedic surgeons. Intraobserver variability 
was analyzed with independent t-test while P<0.05 was 
considered statistically significant.
   Student t-test was used to compare differences between 
groups. Paired t-test was used for assessing changes within 
groups from preoperative measures. A P value of 0.05 was 
chosen as significant.
3. Results
3.1. Clinical findings
   A total of 41 Bryan disc prostheses from 32 patients 
were evaluated. Clinical follow up was introduced with an 
average duration of 33.5 months (range 23 to 44 months). 
Significant change was found in averaged VAS score, that 
was significantly improved from 6.3依2.2 (range from 2 to 9) 
preoperatively to 1.3依1.2 (range from 0 to 4) postoperatively 
(P<0.001). Preoperative averaged JOA score was 14.4依
1.2 (range from 13 to 17) and was significantly improved 
(P<0.001) to 16.3依0.9 (range from 14 to 17) at the last follow-
up (36 months). According to the Odom’s scale, 30 of 32 
patients received excellent to good outcomes, and the 
other two patients performed fair outcomes in the last 
postoperative follow-up.
   Both single level and multi-level groups showed 
improvement of their VAS and JOA scores at the last follow-
up. Compared to preoperative scores, the VAS and JOA 
score at last follow-up for both single level and multi-level 
groups significantly decreased (P<0.05 as shown in Table 
2). Between single level and multi-level groups, there is no 
significant difference at both the preoperative and the last 
follow-up. The detail clinical results of VAS, JOA score and 
Odom’s scale at each follow-up period are shown in Table 3.
Table 2
Clinical results with using VAS and JOA score.
Single level Multi-level
VAS score Pre-operation  5.7依2.3  7.5依1.4
*Last follow-up  1.0依1.1  2.1依0.8
*P values for change from pre-operation in each group <0.001 <0.001
JOA score Pre-operation 14.2依1.3 14.8依1.0
*Last follow-up 16.4依0.9 15.9依0.8
*P values for change from pre-operation in each group < 0.001 0.003
Table 3
Clinical results of VAS,  JOA score and Odom's scale at each follow-
up patients period.
No. of follow-up 
patients [n (%)]
VAS score JOA score Odom's scale†
Pre-op   32 (100) 6.3依2.2 14.4依1.2 NA
1 month   32 (100) 5.2依2.5 13.8依2.2 Excellent/good 27
Fair/poor  5
6 months 28 (88) 3.1依2.1 14.1依2.1 Excellent/good 24
Fair/poor  4
12 months 31 (97) 2.2依1.5 15.4依1.8 Excellent/good 25
Fair/poor  6
18 months 29 (91) 1.9依1.3 15.9依1.1 Excellent/good 25
Fair/poor  4
24 months 26 (81) 1.1依1.3 17.1依1.5 Excellent/good 21
Fair/poor  5
36 months 24 (75) 1.3依1.2 16.3依0.9 Excellent/good 22
Fair/poor  2
†: The data are expressed as number of patients; NA: not applicable.
3.2. Range of motion
   No significant intraobserver variability was found for 
measurements including in single level group (P=0.924), 
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multi-level group (P=0.737), and in all evaluated samples 
(P=0.834). Postoperative angle measurements of the 
functional spinal unit at the implant level demonstrated 
motion of the device in flexion/extension. In consideration 
of mobility restoration, 34 of 41 (83%) implanted prostheses 
preserved sufficient mobility (more than 8 degrees) at the 
treated segment after the procedure in the last follow-up. 
Figures 1 and 2 show two of these cases representing the 
grade of degeneration, pre- and postoperative range of 
motion. 
   The mobility of treated segment in the early follow-up 
of one month postoperatively was comparatively restricted 
[average (8.2依3.4)°, range from 1.7° to 13.8°]. For the 
performance in the last follow-up evaluation of 36 months, 
the mobility was improved [average (9.9依3.2)°, range from 6° 
to 15.2°]. However, there were no statistical differences in 
angular range of motion of these two follow-ups (P=0.243). 
The angular range of motion was smaller than preoperative 
values in early follow-up evaluation but was restored to 
preoperative value at 12 months of the procedure (10.7依4.5)°. 
Distribution of comparative mobility during the period of 
follow-up was respectively illustrated in Figure 3. 
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Figure 3. Distribution of comparative mobility during the periods of follow-up. 
Relative lower mobility in the early follow-ups; Mobility were restored in the 
last follow-ups.
   At the 36 months follow-up, either in the single-level or 
multi-level group, the range of motion exhibited no statistic 
differences compared with preoperative results (P value is 
0.06 and 0.283 respectively). 
3.3. Complications
   There was no prosthesis migration, subsidence, hematoma, 
neurological deficit, infections, or revision occurred in these 
Figure 2. One patient’s preoperative lateral radiograph shows marked osteophyte at C6-7 (a). T2-weighted midsagittal image shows grade V 
cervical intervertebral disc degeneration at C6-7 (b). One-month postoperative lateral radiograph after replacement at C6-7 with a range of 
motion of 0.1° calculated from flexion radiograph (c) and extension radiograph (d). After thirty months, the range of motion is 10.0° calculated 
from flexion (e) and extension (f).
-:  lordosis; +: kyphosis.
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cases. The overall prevalence of heterotopic ossification in 
the 41 levels was 24% (Ten levels). There were one case of 
Class III heterotopic ossification and one case of Class IV 
heterotopic ossification. There are four cases having mild 
osteophyte increase (1.5 to 2 mm) in adjacent level after two 
years follow up based on the X-ray films. Nevertheless, one 
case of transient hoarseness was noted.
 
4. Discussion 
   Since 2002, Bryan discs have been implanted worldwide 
and have been the subject of clinical studies; the short- and 
intermediate-term clinical outcomes associated with Bryan 
disc have also been published[7-9,11]. Riew et al. stated that 
spinal motion maintained with cervical disc replacement 
did not appear to have an adverse effect in the setting 
of myelopathy up to 2 years after replacement[18]. To our 
knowledge and from article reviews, no study has described 
the clinical and radiographic outcomes according to the 
grade of disc degeneration. This study firstly reported the 
clinical and outcomes of surgical treatments of cervical disc 
replacement using Bryan cervical disc prostheses in patients 
with severe cervical disc narrowing.
   The VAS and functional scores are useful indexes for 
evaluating clinical outcomes. In a prospective study with 
2-year follow-up on 99 patients by Sasso et al[9], use of 
Bryan disc for replacement was favored other than anterior 
cervical discectomy and fusion for treatment of patient with 
single-level cervical disc disease; significant improvements 
of Neck Disability Index, neck pain and arm pain VAS 
scores were noted. Two-year follow-up results of Heller 
et al’s report indicated that cervical disc replacement 
achieved superior results compared with fusion in patients 
with persistently symptomatic, single-level cervical disc 
disease[19]. Yoon et al. reported their clinical outcome 
(averagely improved from 8.15 to 1.35) with follow-up 
duration of 11.8 months[12]. Their inclusion criteria included 
single or two level disease between C3-4 and C6-7. Amit 
and Dorward demonstrated that postoperative VAS score 
was significantly improved averagely from 8 to 4 with Bryan 
disc replacement from the 12-month clinical outcomes[20]. 
The indication of marked disc narrowing was excluded. In 
current study, 32 patients with 41 Bryan disc replacements 
for severe cervical disc narrowing were described. The 
majority of treated levels were C4-C5 and C5-C6. The 
similar performance on VAS score was improved from 
7.22 to 2.11. Our results demonstrated the TDR on patients 
with severe cervical disc narrowing seemed to be safe and 
provided good preliminary functional results.
   One of the primary goals of cervical disc replacement is 
to reproduce normal kinematics after implantation. Our 
investigations noted preservation of angular motion at the 
target level at 36 months. This statistically significant finding 
mirrors the findings of other investigators. Duggal et al. have 
demonstrated preservation of motion in Bryan-treated spinal 
segments (from preoperative 10.1° to postoperative 7.8° for up 
to 24 months)[21]. Sasso et al. reported relative lower mobility 
(6.43°) in preoperative compared with their final follow-up 
evaluation using Bryan disc arthroplasty (7.95° at 24 months)
[9]. According to Goffin et al.’s clinical cases with Bryan disc 
replacement, average of range of motion at for one level at two 
year was 9.0°[8]. Their indication intended for use is DDD of the 
cervical spine at any one level or two adjacent levels between 
C3-4 and C6-7. In comparison of postoperative mobility of 
treated segments, restricted mobility was observed in early 
follow-up evaluation (8.2° at one month). Probably, in early 
stage of postoperative recovery, it was under the period of 
adaptation of spinal structure. According to Panjabi’s theory of 
spinal stabilizing system, intervertebral disc as a component 
of passive subsystem was out of function and replaced[22]. 
Several months were spent for mechanisms of adaptation 
and enhancement of spinal stabilizing capacity to restore the 
function of treated segment. With follow-ups over 12 months, 
mobility of treated segments were preserved (10.7° at 12 
months), and no significant adjacent level degeneration was 
observed during the whole period.
   Several postoperative complications for treatment with 
Bryan disc have been reported. Pickett et al. demonstrated 
early and late complications (included neurological 
symptom, heterotopic ossification, implant migration, 
prosthesis failure, etc.) in mechanical and physical 
conditions; the complication rate was 6.2% in average per 
treated level[23]. In this study, no patient required revision 
surgery, and no prosthesis subsidence or migration has been 
encountered. There is 24% incidence rate of heterotopic 
ossification observed in this study. The rate is higher than 
Leung et al.’s study (17.8%)[24]. According to their conclusion, 
male gender was detected to be associated with development 
of heterotopic ossification. In this follow up study, patient 
number with male gender is more than female. 
   In addition, some degenerative cervical diseases 
encompass more than one level. Previous literatures 
concluded that bi-level or tri-level disc replacement 
is feasible and safe and the patients had good outcome 
and restored range of motion in the early and immediate 
postoperative period[8,25]. Some patients underwent multi-
level arthroplasties (7/32 for bi-level and 1/32 for tri-
level arthroplasties) in current study. Effects of number 
of treatment segments were analyzed. As compared to 
preoperative clinical functional data, both single level and 
multi-level groups showed improvement of their VAS and 
JOA results at the 36 months follow-up. Although the cases 
for multi-level disc replacement in the treatment of DDD are 
less in current study, it is believed that the clinical results of 
the cervical artificial disc will be improved for multi-level 
applications with severe cervical disc narrowing. Another 
finding is that mobility of all inserted Bryan discs in single-, 
two- or tri-level introduced seemed no significant difference 
appeared in each implanted segment. Further study should 
carefully take these conditions into considerations to have a 
whole understanding for single- or multi-level replacement.
   Rotational center of the motion unit is not calculated in 
this study. Trajectory for the instant rotational center is 
295Chao-Hung Yeh, MD et al./ Journal of Acute Disease (2014)290-295
important in evaluating the motional quality of human spine. 
However, current study focused on the maximal range of 
flexion/extension activity. Only single center of rotation 
can be defined for each flexion/extension activity, which 
may not provide sufficient information of motional quality 
(i.e. trajectory of instant rotational center). According to the 
special mechanism design, the rotational center of Bryan 
disc would change more significantly in flexion-extension 
than other ball-and-socket type devices. Consequently, 
Bryan disc may perform better mobility than ball-and-
socket type products (i.e. ProDisc-C or Prestige) for the 
patient with severe cervical disc narrowing. The un-
constrained, mobile and more degrees of freedom may be an 
adequate design for severe cervical disc narrowing.
   In conclusions, referring to the clinical outcomes in 
current study, application of Bryan disc for cervical disc 
replacement is effective in treatment of severe cervical 
disc narrowing. Treatments with the disc could preserve 
mobility in flexion/extension activities in current medium-
term follow-ups. Long-term follow-up and retrospective 
evaluation will be required to have a whole understanding 
for the mechanism of cervical disc replacement.
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